Assessing functional performance in the mdx mouse model.

作者: Annemieke Aartsma-Rus , Maaike van Putten

DOI: 10.3791/51303

关键词: Clinical trialMuscular dystrophyFunctional testingmdx mouseTreadmill runningPhysical therapyPhysical medicine and rehabilitationGrip strengthDiseaseMedicineDuchenne muscular dystrophy

摘要: Duchenne muscular dystrophy (DMD) is a severe and progressive muscle wasting disorder for which no cure available. Nevertheless, several potential pharmaceutical compounds gene therapy approaches have progressed into clinical trials. With improvement in function being the most important end point these trials, lot of emphasis has been placed on setting up reliable, reproducible, easy to perform functional tests pre clinically assess function, strength, condition, coordination mdx mouse model DMD. Both invasive noninvasive are Tests that do not exacerbate disease can be used determine natural history effects therapeutic interventions (e.g. forelimb grip strength test, two different hanging using either wire or grid rotarod running). Alternatively, forced treadmill running enhance progression and/or protective pathology. We here describe how commonly reliable reproducible manner. Using protocols based standard operating procedures enables comparison data between laboratories.

参考文章(21)
P Chapillon, R Lalonde, N Jones, J Caston, Early development of synchronized walking on the rotorod in rats: Effects of training and handling Behavioural Brain Research. ,vol. 93, pp. 77- 81 ,(1998) , 10.1016/S0166-4328(97)00137-X
Jill A. Rafael, Yumiko Nitta, Jo Peters, Kay E. Davies, Testing of SHIRPA, a mouse phenotypic assessment protocol, on Dmd(mdx) and Dmd(mdx3cv) dystrophin-deficient mice. Mammalian Genome. ,vol. 11, pp. 725- 728 ,(2000) , 10.1007/S003350010149
Daniel Skuk, Marlyne Goulet, Brigitte Roy, Vincent Piette, Claude H. Côté, Pierre Chapdelaine, Jean-Yves Hogrel, Martin Paradis, Jean-Pierre Bouchard, Michel Sylvain, Jean-Guy Lachance, Jacques P. Tremblay, First test of a ''high-density injection'' protocol for myogenic cell transplantation throughout large volumes of muscles in a Duchenne muscular dystrophy patient: eighteen months follow-up Neuromuscular Disorders. ,vol. 17, pp. 38- 46 ,(2007) , 10.1016/J.NMD.2006.10.003
Silvan M. Klein, Jody Vykoukal, Philipp Lechler, Katharina Zeitler, Sebastian Gehmert, Stephan Schreml, Eckhard Alt, Ulrich Bogdahn, Lukas Prantl, Noninvasive in vivo assessment of muscle impairment in the mdx mouse model – A comparison of two common wire hanging methods with two different results Journal of Neuroscience Methods. ,vol. 203, pp. 292- 297 ,(2012) , 10.1016/J.JNEUMETH.2011.10.001
Dawn E Bowles, Scott WJ McPhee, Chengwen Li, Steven J Gray, Jade J Samulski, Angelique S Camp, Juan Li, Bing Wang, Paul E Monahan, Joseph E Rabinowitz, Joshua C Grieger, Lakshmanan Govindasamy, Mavis Agbandje-McKenna, Xiao Xiao, R Jude Samulski, Phase 1 Gene Therapy for Duchenne Muscular Dystrophy Using a Translational Optimized AAV Vector Molecular Therapy. ,vol. 20, pp. 443- 455 ,(2012) , 10.1038/MT.2011.237
Anne M Connolly, Richard M Keeling, Shobhna Mehta, Alan Pestronk, Joshua R Sanes, Three mouse models of muscular dystrophy: the natural history of strength and fatigue in dystrophin-, dystrophin/utrophin-, and laminin α2-deficient mice Neuromuscular Disorders. ,vol. 11, pp. 703- 712 ,(2001) , 10.1016/S0960-8966(01)00232-2
Maaike van Putten, Margriet Hulsker, Vishna Devi Nadarajah, Sandra H. van Heiningen, Ella van Huizen, Maarten van Iterson, Peter Admiraal, Tobias Messemaker, Johan T. den Dunnen, Peter A. C. 't Hoen, Annemieke Aartsma-Rus, The Effects of Low Levels of Dystrophin on Mouse Muscle Function and Pathology PLoS ONE. ,vol. 7, pp. e31937- ,(2012) , 10.1371/JOURNAL.PONE.0031937
Annamaria De Luca, Beatrice Nico, Jean-François Rolland, Anna Cozzoli, Rosa Burdi, Domenica Mangieri, Viviana Giannuzzi, Antonella Liantonio, Valentina Cippone, Michela De Bellis, Grazia Paola Nicchia, Giulia Maria Camerino, Antonio Frigeri, Maria Svelto, Diana Conte Camerino, Gentamicin treatment in exercised mdx mice: Identification of dystrophin-sensitive pathways and evaluation of efficacy in work-loaded dystrophic muscle. Neurobiology of Disease. ,vol. 32, pp. 243- 253 ,(2008) , 10.1016/J.NBD.2008.07.009
Maaike van Putten, Christa de Winter, Willeke van Roon-Mom, Gert-Jan van Ommen, Peter A.C. ’t Hoen, Annemieke Aartsma-Rus, A 3 months mild functional test regime does not affect disease parameters in young mdx mice Neuromuscular Disorders. ,vol. 20, pp. 273- 280 ,(2010) , 10.1016/J.NMD.2010.02.004